Recent Articles

• ProKidney Set to Present Novel CKD Research at Kidney Week
• Altimmune Reveals Exciting Data on Pemvidutide at AASLD 2025
• Sanofi’s Tzield Advances Towards US Approval for Type 1 Diabetes
• Radiopharm Theranostics Secures A$35 Million Placement Funds
• Mutuum Finance Prepares Major Launch with 17,300 Investors
• Consolidated Lithium Metals: Upcoming Webinar Highlights
• QuickTopUps.com Expands Digital Services in MENAP Region
• b.well Partners with Google to Enhance Personalized Health
• SciSparc and Clearmind's Collaborative Patent on Binge Behavior Care
• BriaCell Unveils Promising Phase 3 Biomarkers at ESMO 2025
• Revolutionary Patent Application by Clearmind Advances Mental Health Solutions
• Image Specialty Partners Welcomes New Executives to Boost Growth
• Canadian Entrepreneurs Remain Resilient in Changing Times
• Exploring the AI as a Service Market: Growth and Insights
• BingX Academy 2.0: Empowering Users in Web3 Education
• Exploring the Depth Sensing Market's Incredible Growth Potential
• Exciting Developments in Gold Mining at Cármenes Project
• Pan Global Expands Drilling Efforts in Cármenes Gold Project
• Future Trends in the Expanding Analytical Chemistry Sector
• Nicely Network Emerges as Leading Reddit Marketing Agency
• Robotics Market Expected to Surge to USD 200 Billion in Coming Years
• Empowering Health Data Management with b.well and Google
• Ituran Location and Control to Release Q3 Results on Nov 18
• Endo Introduces Groundbreaking Generic Glycerol Phenylbutyrate Liquid
• Radiopharm Theranostics Engages in Major Funding Round of A$40M
• Siipet Unveils Innovative AI Tool for Cat Health Monitoring
• Sandstorm Gold Successfully Completes Arrangement with Royal Gold
• Sanofi’s Tzield Awaits FDA Review for Phase 3 Diabetes Treatment
• Horizon Copper Finalizes Arrangement with Royal Gold Success
• Blaqclouds, Inc. Moves Forward with FinCEN MSB Application
• Altimmune to Reveal New Data on Pemvidutide at Major Conference
• CorMedix Inc. Boosts Revenue Predictions with Q3 Highlights
• Engage with Consolidated Lithium Metals' Corporate Insights
• ProKidney's Major Step in Chronic Kidney Disease Treatment Announced
• Innovative AI-Powered Solutions for the Industrial Sector
• Aventis Energy Unveils Promising Uranium Assay Results
• PMGC Holdings Builds Strong Momentum with $711K Sales Backlog
• BriaCell Unveils Pivotal Biomarker Study Findings at ESMO
• Churchill Resources Uncovers Significant Findings at Frost Cove Mine
• Christina Lake Cannabis Secures Credit and Equipment Lease
• Enzo Villani to Address Ethical Innovation at World Summit
• Replimune's BLA Resubmission for RP1 Advances Cancer Treatment
• AI Maverick Intel Transitions to AIMV Ticker for Future Growth
• In-Depth Overview of EMPAVELI Efficacy in Kidney Diseases
• Strategic Leadership Growth at Stella-Jones Inc. Board
• Exciting Progress in Clinical Trials for Innovative MS Treatment
• BPGbio and Mount Sinai's Study Offers New Hope for Neurodegenerative Diseases
• Key Additions to Stella-Jones Board Enhance Strategic Vision
• Understanding Schouw & Co.'s Share Buy-Back Programme 2025
• J-Star Embraces Nasdaq's Collaboration for Vietnam's Financial Hub